Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Duloxetine | The risk or severity of orthostatic hypotension and syncope can be increased when Carbetocin is combined with Duloxetine. |
| Levodopa | The risk or severity of hypotension and orthostatic hypotension can be increased when Carbetocin is combined with Levodopa. |
| Risperidone | Carbetocin may increase the hypotensive activities of Risperidone. |
| Carboprost tromethamine | Carboprost tromethamine may increase the uterotonic activities of Carbetocin. |
| Dinoprostone | The risk or severity of adverse effects can be increased when Dinoprostone is combined with Carbetocin. |
| Misoprostol | The risk or severity of adverse effects can be increased when Misoprostol is combined with Carbetocin. |
| Aripiprazole | Aripiprazole may increase the hypotensive activities of Carbetocin. |
| Aripiprazole lauroxil | Aripiprazole lauroxil may increase the hypotensive activities of Carbetocin. |
| Nicorandil | Nicorandil may increase the hypotensive activities of Carbetocin. |
| Linezolid | Linezolid may increase the orthostatic hypotensive activities of Carbetocin. |
| Furazolidone | Furazolidone may increase the orthostatic hypotensive activities of Carbetocin. |
| Procaine | Procaine may increase the orthostatic hypotensive activities of Carbetocin. |
| Tranylcypromine | Tranylcypromine may increase the orthostatic hypotensive activities of Carbetocin. |
| Phenelzine | Phenelzine may increase the orthostatic hypotensive activities of Carbetocin. |
| Minaprine | Minaprine may increase the orthostatic hypotensive activities of Carbetocin. |
| Selegiline | Selegiline may increase the orthostatic hypotensive activities of Carbetocin. |
| Procarbazine | Procarbazine may increase the orthostatic hypotensive activities of Carbetocin. |
| Moclobemide | Moclobemide may increase the orthostatic hypotensive activities of Carbetocin. |
| Isocarboxazid | Isocarboxazid may increase the orthostatic hypotensive activities of Carbetocin. |
| Rasagiline | Rasagiline may increase the orthostatic hypotensive activities of Carbetocin. |
| Pargyline | Pargyline may increase the orthostatic hypotensive activities of Carbetocin. |
| Clorgiline | Clorgiline may increase the orthostatic hypotensive activities of Carbetocin. |
| Iproniazid | Iproniazid may increase the orthostatic hypotensive activities of Carbetocin. |
| Nialamide | Nialamide may increase the orthostatic hypotensive activities of Carbetocin. |
| Safinamide | Safinamide may increase the orthostatic hypotensive activities of Carbetocin. |
| 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline | 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Carbetocin. |
| Methylene blue | Methylene blue may increase the orthostatic hypotensive activities of Carbetocin. |
| Hydracarbazine | Hydracarbazine may increase the orthostatic hypotensive activities of Carbetocin. |
| Pirlindole | Pirlindole may increase the orthostatic hypotensive activities of Carbetocin. |
| Toloxatone | Toloxatone may increase the orthostatic hypotensive activities of Carbetocin. |
| Benmoxin | Benmoxin may increase the orthostatic hypotensive activities of Carbetocin. |
| Mebanazine | Mebanazine may increase the orthostatic hypotensive activities of Carbetocin. |
| Octamoxin | Octamoxin may increase the orthostatic hypotensive activities of Carbetocin. |
| Pheniprazine | Pheniprazine may increase the orthostatic hypotensive activities of Carbetocin. |
| Phenoxypropazine | Phenoxypropazine may increase the orthostatic hypotensive activities of Carbetocin. |
| Pivhydrazine | Pivhydrazine may increase the orthostatic hypotensive activities of Carbetocin. |
| Safrazine | Safrazine may increase the orthostatic hypotensive activities of Carbetocin. |
| Caroxazone | Caroxazone may increase the orthostatic hypotensive activities of Carbetocin. |
| Harmaline | Harmaline may increase the orthostatic hypotensive activities of Carbetocin. |
| Brofaromine | Brofaromine may increase the orthostatic hypotensive activities of Carbetocin. |
| Butalbital | Butalbital may increase the hypotensive activities of Carbetocin. |
| Pentobarbital | Pentobarbital may increase the hypotensive activities of Carbetocin. |
| Secobarbital | Secobarbital may increase the hypotensive activities of Carbetocin. |
| Methohexital | Methohexital may increase the hypotensive activities of Carbetocin. |
| Thiopental | Thiopental may increase the hypotensive activities of Carbetocin. |
| Primidone | Primidone may increase the hypotensive activities of Carbetocin. |
| Methylphenobarbital | Methylphenobarbital may increase the hypotensive activities of Carbetocin. |
| Thiamylal | Thiamylal may increase the hypotensive activities of Carbetocin. |
| Phenobarbital | Phenobarbital may increase the hypotensive activities of Carbetocin. |
| Amobarbital | Amobarbital may increase the hypotensive activities of Carbetocin. |
| Hexobarbital | Hexobarbital may increase the hypotensive activities of Carbetocin. |
| Barbital | Barbital may increase the hypotensive activities of Carbetocin. |
| Barbexaclone | Barbexaclone may increase the hypotensive activities of Carbetocin. |
| Butabarbital | Butabarbital may increase the hypotensive activities of Carbetocin. |
| Aldesleukin | The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carbetocin. |
| Streptokinase | The risk or severity of adverse effects can be increased when Streptokinase is combined with Carbetocin. |
| Methyclothiazide | The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Carbetocin. |
| Ropinirole | The risk or severity of adverse effects can be increased when Ropinirole is combined with Carbetocin. |
| Morphine | The risk or severity of adverse effects can be increased when Morphine is combined with Carbetocin. |
| Ropivacaine | The risk or severity of adverse effects can be increased when Ropivacaine is combined with Carbetocin. |
| Bupivacaine | The risk or severity of adverse effects can be increased when Bupivacaine is combined with Carbetocin. |
| Tolcapone | The risk or severity of adverse effects can be increased when Tolcapone is combined with Carbetocin. |
| Olanzapine | The risk or severity of adverse effects can be increased when Olanzapine is combined with Carbetocin. |
| Clozapine | The risk or severity of adverse effects can be increased when Clozapine is combined with Carbetocin. |
| Triamterene | The risk or severity of adverse effects can be increased when Triamterene is combined with Carbetocin. |
| Pramipexole | The risk or severity of adverse effects can be increased when Pramipexole is combined with Carbetocin. |
| Spironolactone | The risk or severity of adverse effects can be increased when Spironolactone is combined with Carbetocin. |
| Nitric Oxide | The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Carbetocin. |
| Imipramine | The risk or severity of adverse effects can be increased when Imipramine is combined with Carbetocin. |
| Chlorpromazine | The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Carbetocin. |
| Nabilone | The risk or severity of adverse effects can be increased when Nabilone is combined with Carbetocin. |
| Sotalol | The risk or severity of adverse effects can be increased when Sotalol is combined with Carbetocin. |
| Amiloride | The risk or severity of adverse effects can be increased when Amiloride is combined with Carbetocin. |
| Clofarabine | The risk or severity of adverse effects can be increased when Clofarabine is combined with Carbetocin. |
| Dexmedetomidine | The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Carbetocin. |
| Verapamil | The risk or severity of adverse effects can be increased when Verapamil is combined with Carbetocin. |
| Thioridazine | The risk or severity of adverse effects can be increased when Thioridazine is combined with Carbetocin. |
| Amphotericin B | The risk or severity of adverse effects can be increased when Amphotericin B is combined with Carbetocin. |
| Furosemide | The risk or severity of adverse effects can be increased when Furosemide is combined with Carbetocin. |
| Tizanidine | The risk or severity of adverse effects can be increased when Tizanidine is combined with Carbetocin. |
| Methazolamide | The risk or severity of adverse effects can be increased when Methazolamide is combined with Carbetocin. |
| Tamsulosin | The risk or severity of adverse effects can be increased when Tamsulosin is combined with Carbetocin. |
| Sufentanil | The risk or severity of adverse effects can be increased when Sufentanil is combined with Carbetocin. |
| Apomorphine | The risk or severity of adverse effects can be increased when Apomorphine is combined with Carbetocin. |
| Mannitol | The risk or severity of adverse effects can be increased when Mannitol is combined with Carbetocin. |
| Isoflurane | The risk or severity of adverse effects can be increased when Isoflurane is combined with Carbetocin. |
| Propofol | The risk or severity of adverse effects can be increased when Propofol is combined with Carbetocin. |
| Conivaptan | The risk or severity of adverse effects can be increased when Conivaptan is combined with Carbetocin. |
| Isosorbide dinitrate | The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Carbetocin. |
| Bumetanide | The risk or severity of adverse effects can be increased when Bumetanide is combined with Carbetocin. |
| Remifentanil | The risk or severity of adverse effects can be increased when Remifentanil is combined with Carbetocin. |
| Etacrynic acid | The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Carbetocin. |
| Levosimendan | The risk or severity of adverse effects can be increased when Levosimendan is combined with Carbetocin. |
| Dipyridamole | The risk or severity of adverse effects can be increased when Dipyridamole is combined with Carbetocin. |
| Levobupivacaine | The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Carbetocin. |
| Isosorbide mononitrate | The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Carbetocin. |
| Thalidomide | The risk or severity of adverse effects can be increased when Thalidomide is combined with Carbetocin. |
| Iloprost | The risk or severity of adverse effects can be increased when Iloprost is combined with Carbetocin. |
| Papaverine | The risk or severity of adverse effects can be increased when Papaverine is combined with Carbetocin. |
| Nifedipine | The risk or severity of adverse effects can be increased when Nifedipine is combined with Carbetocin. |